WHO ICTRP trial
A trial to test if decitabine can be used to treat patients with Myelodysplastic…
EUCTR2009-017098-40-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-017098-40-GB |
|---|---|
| Public title | A trial to test if decitabine can be used to treat patients with Myelodysplastic Syndrome (MDS) that have already been treated with Azacitidine (AZA) |
| Scientific title | Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure (DEC-MDS) - DEC-MDS |
| Primary sponsor | King's College London |
| Secondary sponsors | King's College Hospital NHS Foundation Trust |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Myelodysplastic Syndromes Acute Myeloid Leukaemia Chronic Myelomonocytic Leukaemia MedDRA version: 14.1 Level: LLT Classification code 10054350 Term: Chronic myelomonocytic leukemia System Organ Class: 10029104 - Neoplasms benign, malignant… |
| Interventions | Trade Name: Dacogen Product Name: DECITABINE Pharmaceutical Form: Powder for solution for infusion INN or Proposed INN: DACOGEN CAS Number: 2353-33-5 Concentration unit: mg/m2 milligram(s)/square meter Concentration type: equal… |
| Registration date | Jun 29, 2010 |
| Target size | 50 |
| Secondary IDs | DEC-MDS |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: